BioSpecifics Technologies Corporation to Present at CapStone Investments' Third Annual Small-Cap Investor Conference

LYNBROOK, N.Y., July 22 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC - News), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming CapStone Investments' Third Annual Small-Cap Investor Conference on Wednesday, July 29, 2009, at 9:30am CT at the Hyatt Regency in Milwaukee, WI.

Back to news